Avava key facts
as of Oct 2026- Developer of 3D precision laser treatment technology designed to rejuvenate skin color.
- Avava is valued at approximately $48.8M as of Oct 2026 (last reported valuation).
- It has raised $85.6M; the latest was Later Stage VC ($19.6M) in Feb 2026.
- Notable investors include Catalio Capital Management, Craig Drill, Jeisys Medical.
- Status: Privately Held (backing).
Avava's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·Watch Avava: the Monday email on marks, rounds and moves
Avava funding rounds
No funding rounds for Avava are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Avava
3Avava valuation
Avava's last reported valuation was $48.8 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Avava investors
3 investors are on record for Avava, including Catalio Capital Management, Craig Drill and Jeisys Medical.
About Avava
Developer of 3D precision laser treatment technology designed to rejuvenate skin color. The company's treatment technology looks after melasma and post-inflammatory hyperpigmentation problems, enabling healthcare providers to offer tissue treatments to their patients.
- Sector
- Healthcare
- HQ
- Waltham, MA, United States
- Founded
- 2016
- Employees
- 66
- Website
- avavaskin.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.